HEADER LYASE 07-MAY-02 1LP6 TITLE CRYSTAL STRUCTURE OF OROTIDINE MONOPHOSPHATE DECARBOXYLASE COMPLEXED TITLE 2 WITH CMP COMPND MOL_ID: 1; COMPND 2 MOLECULE: OROTIDINE MONOPHOSPHATE DECARBOXYLASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: OMP DECARBOXYLASE, OMPDCASE; COMPND 5 EC: 4.1.1.23; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ARCHAEA; SOURCE 3 ORGANISM_TAXID: 2157; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 EXPRESSION_SYSTEM_PLASMID: PET15B KEYWDS TIM BARREL, LYASE EXPDTA X-RAY DIFFRACTION AUTHOR N.WU,E.F.PAI REVDAT 5 14-FEB-24 1LP6 1 REMARK SEQADV REVDAT 4 31-JAN-18 1LP6 1 REMARK REVDAT 3 24-FEB-09 1LP6 1 VERSN REVDAT 2 01-APR-03 1LP6 1 JRNL REVDAT 1 07-AUG-02 1LP6 0 JRNL AUTH N.WU,E.F.PAI JRNL TITL CRYSTAL STRUCTURES OF INHIBITOR COMPLEXES REVEAL AN JRNL TITL 2 ALTERNATE BINDING MODE IN OROTIDINE-5'-MONOPHOSPHATE JRNL TITL 3 DECARBOXYLASE. JRNL REF J.BIOL.CHEM. V. 277 28080 2002 JRNL REFN ISSN 0021-9258 JRNL PMID 12011084 JRNL DOI 10.1074/JBC.M202362200 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 0.9 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.47 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.8 REMARK 3 NUMBER OF REFLECTIONS : 32255 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.192 REMARK 3 FREE R VALUE : 0.240 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1326 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.02 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.70 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5036 REMARK 3 BIN R VALUE (WORKING SET) : 0.2150 REMARK 3 BIN FREE R VALUE : 0.2710 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 216 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.018 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3195 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 42 REMARK 3 SOLVENT ATOMS : 162 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 14.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 10.18000 REMARK 3 B22 (A**2) : -4.70000 REMARK 3 B33 (A**2) : -5.48000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 3.25000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.26 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.18 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.20 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.950 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.670 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.450 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.700 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.990 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.37 REMARK 3 BSOL : 48.16 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : CMP.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : CMP.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1LP6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-MAY-02. REMARK 100 THE DEPOSITION ID IS D_1000016154. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-JUN-01 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 14-BM-C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32661 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.97 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: EPMR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.04 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.09 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: TRISODIUM CITRATE, 1,2,3-HEPTANETRIOL, REMARK 280 12-CROWN-4, PH 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 25K, TEMPERATURE 298.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 27.83150 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL UNIT IS A DIMER. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4360 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16750 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -39.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU A 1 REMARK 465 ARG A 2 REMARK 465 SER A 3 REMARK 465 ARG A 4 REMARK 465 ARG A 5 REMARK 465 VAL A 6 REMARK 465 ASP A 7 REMARK 465 VAL A 8 REMARK 465 GLY A 181 REMARK 465 VAL A 182 REMARK 465 GLY A 183 REMARK 465 ALA A 184 REMARK 465 GLN A 185 REMARK 465 GLY A 186 REMARK 465 GLY A 187 REMARK 465 ASP A 188 REMARK 465 PRO A 189 REMARK 465 ILE A 222 REMARK 465 LYS A 223 REMARK 465 ASP A 224 REMARK 465 LEU A 225 REMARK 465 LEU A 226 REMARK 465 ILE A 227 REMARK 465 PRO A 228 REMARK 465 GLU A 229 REMARK 465 LEU B 1001 REMARK 465 ARG B 1002 REMARK 465 SER B 1003 REMARK 465 ARG B 1004 REMARK 465 ARG B 1005 REMARK 465 VAL B 1006 REMARK 465 ASP B 1007 REMARK 465 VAL B 1008 REMARK 465 MET B 1009 REMARK 465 ASP B 1010 REMARK 465 VAL B 1182 REMARK 465 GLY B 1183 REMARK 465 ALA B 1184 REMARK 465 GLN B 1185 REMARK 465 GLY B 1186 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 13 14.72 59.69 REMARK 500 ALA A 74 46.57 -145.24 REMARK 500 ASP A 75 -166.12 -114.45 REMARK 500 ARG A 118 -165.45 -118.28 REMARK 500 PHE A 134 -39.99 -130.87 REMARK 500 LEU A 193 0.83 -69.09 REMARK 500 ALA B1074 46.67 -145.99 REMARK 500 PHE B1134 -36.25 -134.31 REMARK 500 ARG B1160 97.28 61.79 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE C5P A 2001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE C5P B 2002 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1LOL RELATED DB: PDB REMARK 900 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE COMPLEXED WITH XMP REMARK 900 RELATED ID: 1LOQ RELATED DB: PDB REMARK 900 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE COMPLEXED WITH UMP REMARK 900 RELATED ID: 1LOR RELATED DB: PDB REMARK 900 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE COMPLEXED WITH BMP REMARK 900 RELATED ID: 1LOS RELATED DB: PDB REMARK 900 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE MUTANT DELTAR203A REMARK 900 COMPLEXED WITH 6-AZAUMP' REMARK 999 REMARK 999 SEQUENCE REMARK 999 AUTHORS STATE THAT ALTHOUGH RESIDUES 1 AND 1001 ARE MET REMARK 999 AND RESIDUES 101 AND 1101 ARE ARG ACCORDING TO THE REMARK 999 SWISSPROT ENTRY, RESIDUES 1 AND 1001 WERE LEU AND RESIDUES REMARK 999 101 AND 1101 WERE PRO IN THE ORIGINAL CONSTRUCT CLONED REMARK 999 OF MT GENOMIC DNA. DBREF 1LP6 A 1 228 UNP O26232 PYRF_METTH 1 228 DBREF 1LP6 B 1001 1228 UNP O26232 PYRF_METTH 1 228 SEQADV 1LP6 LEU A 1 UNP O26232 MET 1 SEE REMARK 999 SEQADV 1LP6 PRO A 101 UNP O26232 ARG 101 SEE REMARK 999 SEQADV 1LP6 ILE A 227 UNP O26232 ASN 227 CONFLICT SEQADV 1LP6 GLU A 229 UNP O26232 INSERTION SEQADV 1LP6 LEU B 1001 UNP O26232 MET 1 SEE REMARK 999 SEQADV 1LP6 PRO B 1101 UNP O26232 ARG 101 SEE REMARK 999 SEQADV 1LP6 ILE B 1227 UNP O26232 ASN 227 CONFLICT SEQADV 1LP6 GLU B 1229 UNP O26232 INSERTION SEQRES 1 A 229 LEU ARG SER ARG ARG VAL ASP VAL MET ASP VAL MET ASN SEQRES 2 A 229 ARG LEU ILE LEU ALA MET ASP LEU MET ASN ARG ASP ASP SEQRES 3 A 229 ALA LEU ARG VAL THR GLY GLU VAL ARG GLU TYR ILE ASP SEQRES 4 A 229 THR VAL LYS ILE GLY TYR PRO LEU VAL LEU SER GLU GLY SEQRES 5 A 229 MET ASP ILE ILE ALA GLU PHE ARG LYS ARG PHE GLY CYS SEQRES 6 A 229 ARG ILE ILE ALA ASP PHE LYS VAL ALA ASP ILE PRO GLU SEQRES 7 A 229 THR ASN GLU LYS ILE CYS ARG ALA THR PHE LYS ALA GLY SEQRES 8 A 229 ALA ASP ALA ILE ILE VAL HIS GLY PHE PRO GLY ALA ASP SEQRES 9 A 229 SER VAL ARG ALA CYS LEU ASN VAL ALA GLU GLU MET GLY SEQRES 10 A 229 ARG GLU VAL PHE LEU LEU THR GLU MET SER HIS PRO GLY SEQRES 11 A 229 ALA GLU MET PHE ILE GLN GLY ALA ALA ASP GLU ILE ALA SEQRES 12 A 229 ARG MET GLY VAL ASP LEU GLY VAL LYS ASN TYR VAL GLY SEQRES 13 A 229 PRO SER THR ARG PRO GLU ARG LEU SER ARG LEU ARG GLU SEQRES 14 A 229 ILE ILE GLY GLN ASP SER PHE LEU ILE SER PRO GLY VAL SEQRES 15 A 229 GLY ALA GLN GLY GLY ASP PRO GLY GLU THR LEU ARG PHE SEQRES 16 A 229 ALA ASP ALA ILE ILE VAL GLY ARG SER ILE TYR LEU ALA SEQRES 17 A 229 ASP ASN PRO ALA ALA ALA ALA ALA GLY ILE ILE GLU SER SEQRES 18 A 229 ILE LYS ASP LEU LEU ILE PRO GLU SEQRES 1 B 229 LEU ARG SER ARG ARG VAL ASP VAL MET ASP VAL MET ASN SEQRES 2 B 229 ARG LEU ILE LEU ALA MET ASP LEU MET ASN ARG ASP ASP SEQRES 3 B 229 ALA LEU ARG VAL THR GLY GLU VAL ARG GLU TYR ILE ASP SEQRES 4 B 229 THR VAL LYS ILE GLY TYR PRO LEU VAL LEU SER GLU GLY SEQRES 5 B 229 MET ASP ILE ILE ALA GLU PHE ARG LYS ARG PHE GLY CYS SEQRES 6 B 229 ARG ILE ILE ALA ASP PHE LYS VAL ALA ASP ILE PRO GLU SEQRES 7 B 229 THR ASN GLU LYS ILE CYS ARG ALA THR PHE LYS ALA GLY SEQRES 8 B 229 ALA ASP ALA ILE ILE VAL HIS GLY PHE PRO GLY ALA ASP SEQRES 9 B 229 SER VAL ARG ALA CYS LEU ASN VAL ALA GLU GLU MET GLY SEQRES 10 B 229 ARG GLU VAL PHE LEU LEU THR GLU MET SER HIS PRO GLY SEQRES 11 B 229 ALA GLU MET PHE ILE GLN GLY ALA ALA ASP GLU ILE ALA SEQRES 12 B 229 ARG MET GLY VAL ASP LEU GLY VAL LYS ASN TYR VAL GLY SEQRES 13 B 229 PRO SER THR ARG PRO GLU ARG LEU SER ARG LEU ARG GLU SEQRES 14 B 229 ILE ILE GLY GLN ASP SER PHE LEU ILE SER PRO GLY VAL SEQRES 15 B 229 GLY ALA GLN GLY GLY ASP PRO GLY GLU THR LEU ARG PHE SEQRES 16 B 229 ALA ASP ALA ILE ILE VAL GLY ARG SER ILE TYR LEU ALA SEQRES 17 B 229 ASP ASN PRO ALA ALA ALA ALA ALA GLY ILE ILE GLU SER SEQRES 18 B 229 ILE LYS ASP LEU LEU ILE PRO GLU HET C5P A2001 21 HET C5P B2002 21 HETNAM C5P CYTIDINE-5'-MONOPHOSPHATE FORMUL 3 C5P 2(C9 H14 N3 O8 P) FORMUL 5 HOH *162(H2 O) HELIX 1 1 VAL A 11 ASN A 13 5 3 HELIX 2 2 ASN A 23 ARG A 35 1 13 HELIX 3 3 TYR A 45 GLY A 52 1 8 HELIX 4 4 ASP A 54 GLY A 64 1 11 HELIX 5 5 ILE A 76 ALA A 90 1 15 HELIX 6 6 GLY A 102 GLY A 117 1 16 HELIX 7 7 PHE A 134 LEU A 149 1 16 HELIX 8 8 ARG A 160 GLY A 172 1 13 HELIX 9 9 GLU A 191 PHE A 195 5 5 HELIX 10 10 GLY A 202 LEU A 207 1 6 HELIX 11 11 ASN A 210 GLU A 220 1 11 HELIX 12 12 VAL B 1011 ASN B 1013 5 3 HELIX 13 13 ASN B 1023 ARG B 1035 1 13 HELIX 14 14 TYR B 1045 GLY B 1052 1 8 HELIX 15 15 MET B 1053 GLY B 1064 1 12 HELIX 16 16 ILE B 1076 ALA B 1090 1 15 HELIX 17 17 GLY B 1102 GLY B 1117 1 16 HELIX 18 18 PHE B 1134 GLY B 1150 1 17 HELIX 19 19 ARG B 1160 GLY B 1172 1 13 HELIX 20 20 PRO B 1189 ARG B 1194 1 6 HELIX 21 21 GLY B 1202 LEU B 1207 1 6 HELIX 22 22 ASN B 1210 LEU B 1226 1 17 SHEET 1 A 9 LEU A 15 MET A 19 0 SHEET 2 A 9 THR A 40 GLY A 44 1 O LYS A 42 N LEU A 17 SHEET 3 A 9 ARG A 66 VAL A 73 1 O ASP A 70 N ILE A 43 SHEET 4 A 9 ALA A 94 HIS A 98 1 O ALA A 94 N ALA A 69 SHEET 5 A 9 GLU A 119 LEU A 123 1 O LEU A 123 N VAL A 97 SHEET 6 A 9 ASN A 153 VAL A 155 1 O ASN A 153 N LEU A 122 SHEET 7 A 9 PHE A 176 SER A 179 1 O PHE A 176 N TYR A 154 SHEET 8 A 9 ALA A 198 VAL A 201 1 O ILE A 200 N SER A 179 SHEET 9 A 9 LEU A 15 MET A 19 1 N ILE A 16 O VAL A 201 SHEET 1 B 9 LEU B1015 ALA B1018 0 SHEET 2 B 9 THR B1040 GLY B1044 1 O LYS B1042 N LEU B1017 SHEET 3 B 9 ARG B1066 VAL B1073 1 O ASP B1070 N ILE B1043 SHEET 4 B 9 ALA B1094 HIS B1098 1 O ALA B1094 N ALA B1069 SHEET 5 B 9 GLU B1119 LEU B1123 1 O LEU B1123 N VAL B1097 SHEET 6 B 9 ASN B1153 VAL B1155 1 O ASN B1153 N LEU B1122 SHEET 7 B 9 PHE B1176 PRO B1180 1 O PHE B1176 N TYR B1154 SHEET 8 B 9 ALA B1198 VAL B1201 1 O ILE B1200 N SER B1179 SHEET 9 B 9 LEU B1015 ALA B1018 1 N ILE B1016 O ILE B1199 CISPEP 1 ASP B 1188 PRO B 1189 0 0.04 SITE 1 AC1 12 ALA A 18 ASP A 20 LYS A 42 SER A 158 SITE 2 AC1 12 PRO A 180 GLY A 202 ARG A 203 HOH A3013 SITE 3 AC1 12 HOH A3015 HOH A3121 HOH A3153 HOH A3162 SITE 1 AC2 15 ALA B1018 ASP B1020 LYS B1042 SER B1158 SITE 2 AC2 15 PRO B1180 GLY B1202 ARG B1203 HOH B3044 SITE 3 AC2 15 HOH B3105 HOH B3116 HOH B3123 HOH B3154 SITE 4 AC2 15 HOH B3156 HOH B3159 HOH B3161 CRYST1 57.130 55.663 65.838 90.00 94.77 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017504 0.000000 0.001462 0.00000 SCALE2 0.000000 0.017965 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015242 0.00000